POSC109 Cost-Effectiveness Analysis of Reference Recombinant Human Follicle-Stimulating Hormone ALFA (R-HFSH-ALFA) and Urinary Highly Purified Menopausal Gonadotropin (HMG-HP) Based on DATA from a Large German Registry
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.514
https://www.valueinhealthjournal.com/article/S1098-3015(21)02309-3/fulltext
Title :
POSC109 Cost-Effectiveness Analysis of Reference Recombinant Human Follicle-Stimulating Hormone ALFA (R-HFSH-ALFA) and Urinary Highly Purified Menopausal Gonadotropin (HMG-HP) Based on DATA from a Large German Registry
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02309-3&doi=10.1016/j.jval.2021.11.514
First page :
Section Title :
Open access? :
No
Section Order :
10049